Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse | A. Verier | M. Valis | L. Kappos | S. Broadley | J. Lechner-Scott | M. Duddy | Erik Strauss | M. Slee | J. Pollard | A. Kermode | A. Traboulsee | N. Makris | M. Sailer | F. Klostermann | P. Hartikainen | J. Correale | M. Trojano | C. Constantinescu | G. Nagels | M. Dufek | E. Scarpini | F. Viallet | P. Busson | F. Grand'Maison | H. Wiendl | B. Tackenberg | E. Havrdová | H. Butzkueven | A. Ghezzi | S. Meuth | E. Eisenberg | M. Maschke | K. Koivisto | C. Gasperini | I. Elovaara | J. Grimaud | M. Schreiber | C. Plummer | F. Schmitz | J. Jaeger | T. Brosch | C. Sindic | A. M. de Noordhout | D. Jichici | A. Kyritsis | L. Airas | M. Gugenheim | D. Molitor | A. Bitsch | F. Sellal | S. Belachew | R. Mantegazza | W. Verhagen | D. Cottrell | M. Amato | S. Frequin | Z. Katsarava | D. Rog | T. Harrower | W. Rashid | A. Lugaresi | M. Färkkilä | M. Brozman | M. Wuttke | N. Grigoriadis | R. Nicholas | K. Myhr | F. Pellegrini | B. Kieseier | H. Tumani | A. Tavernarakis | D. Decoo | Andreas Link | C. Menges | R. Phan-Ba | Y. Lapierre | J. Debruyne | R. Linker | A. van der Zwart | P. Duquette | J. de Sá | C. Kleinschnitz | M. Kremenchutzky | Christoph Lassek | M. Namaka | P. O'Connor | A. Moulignier | R. Hupperts | A. Berthele | M. Boggild | M. D'hooghe | B. Dubois | M. Schwab | S. Schimrigk | B. Ondzé | T. Spelman | V. van Pesch | N. Deri | O. Gray | E. van Munster | P. Desfontaines | R. Macdonell | B. Barroso | L. Harms | E. Farbu | E. Montanari | A. Bertolotto | K. Alstadhaug | C. Franke | B. Wildemann | L. Klotz | J. Seppä | G. Vorobeychik | G. Mazibrada | A. Bayas | E. de Smet | S. Hodgkinson | F. Doemges | T. Postert | K. Angstwurm | J. Moll | M. Horn | M. Marrosu | I. Lavenu | A. Al-araji | V. Bhan | C. Ramo | H. Koendgen | J. Bufler | R. Lo | O. Kastrup | A. Plaitakis | P. Gérard | V. Delvaux | M. Vlaicu | C. Ballario | C. Stenzel | P. Hautecoeur | A. Caride | O. Škoda | C. Grothe | B. Kallmann | R. Berkenfeld | Stephan Wiehler | D. Mitsikostas | S. Schmidt | François Ziegler | A. Harmjanz | A. Morganho | S. Martínez-Yélamos | T. Arbizu | R. Horn | M. Sá | B. van Wijmeersch | C. Nifle | K. Hellwig | Michael Barnett | P. Seeldrayers | B. Willekens | L. Vanopdenbosch | E. Klímová | J. Szilasiová | M. Vachová | K. Junge | M. Veloso | E. Meluzínová | M. Coustans | P. Štourač | R. Midgard | J. Haas | F. Jacques | A. Kwiatkowski | A. Bergmann | V. Donáth | J. Faiss | K. Gehring | D. Guillaume | G. Hengstman | U. Polzer | S. Rauer | G. Reifschneider | E. Schlegel | H. Schrijver | A. Siever | L. Visser | Yi Chen | Q. Dong | C. Kneebone | J. King | N. Saines | V. Bissay | R. Crols | A. Symons | R. Medaer | A. Lysandropoulos | M. Vokaer | K. Geens | Christina Willems | P. Denayer | M. Bureau | C. Retif | M. Dupuis | O. Bouquiaux | P. Vanderdonckt | W. van Landegem | J. Caekebeke | E. Van Ingelghem | K. Peeters | E. Urbain | I. Declercq | E. Vanroose | A. Wibail | Emmanuel Barthomolé | M. Ursell | M. E. Sweet | Melad Shawush | Stan Hashimoto | Paul Marchetti | G. MacLean | B. Stewart | J. Paulseth | R. Taláb | O. Zapletalová | V. Sládková | A. Novotná | R. Vancurová | Libuse Lhotaková | J. Fiedler | D. Doležil | I. Štětkářová | Adela Rehankova | Petr Pšenica | Veronika Ulehlova | S. Feketova | Sarasoja Taneli | T. Pirttila | P. Louchart | O. Ille | J. P. Thenint | E. Godet | Marcel Maillet Vioud | R. Colamarino | Audrey Kopf | C. Billy | B. Huttin | J. Borsotti | P. Devos | Jean bertin N Kendjuo | Stéphane Chapuis | N. Daluzeau | G. Angibaud | Marie-Sylvie Artaud Uriot | Samir Ismail | R. Devy | Manuel Suceveanu | M. Wagner | S. Marcel | F. Derouiche | Sohrab Mostoufizadehghalamfarsa | S. Delalande | I. Ruggieri | Catherine Bossu Van Nieuwenhuyse | Carmen Gurau Vasilescu | C. Vongsouthi | O. Anne | Joséphine Amevigbe | J. Servan | M. Mérienne | P. Eck | S. Berroir | J. Larrieu | C. Giendaj | I. Malkoun | A. Pouliquen | G. Garrigues | O. Delerue | P. Giraud | J. Gere | J. Vaunaize | O. Dereeper | Nicolas Seiller | R. Alsassa | V. Neuville | J. Faucheux | Patricia Bernady | G. Fanjaud | M. Schroeter | Sylke Schlemilch-Paschen | Thomas Lange | Kin-Arno Bohr | K. Jendroska | Elisabeth Rehkopf | P. Scholz | Uwe Mauz | H. Stratmann | V. Siefjediers | M. Prantl | R. Zellner | A. Zellner | Valerina Bacay | M. Freidel | J. Drews | C. Neudert | Said Masri | W. Heuberger | B. Trausch | O. Ruhnke | Serena Scarel | Kathlen Bach | Michael Ernst | H. Landefeld | N. Richter | Michael Krause | Alezander Dressel | Roland Ruth | K. Anvari | Jens Gossling | C. Schenk | O. Tiedge | Lutz Bode | H. Eder | Oliver Pfeffer | Reinhard Krug | Eberhard Fleischer | I. Peglau | Borries Kukowski | B. Herting | K. Guthke | Jurgen Schierenbeck | B. Brockmeier | H. Albrecht | Regine Augspach-Hofmann | Stefan Gunther | M. Redbrake | Klaus Buchner | Thomas Gratz | Rolf Horn | Matthias Kittlitz | Gabriele Vulturius | P. Hinse | R. Malessa | U. Kausch | M. Gullekes | Markus Fickinger | W. Wenzel | Ingolf C. Botefur | M. Lang | Ulrich Eckhardt | S. Cursiefen | I. Schuetze | Eva Rohm | H. Stienker-Fisse | Johannes Bohringer | M. Maurer | Eberhard Bause | Ronald Wersching | Reinhardt Dachsel | S. Domke | Frank P. Hoffman | K. Roch | U. Ziebold | Bernhard Buehler | Judith Faiss | K. Knop | W. Koehler | G. Gramsl | Benedicta Kuhnler | F. Stogbauer | Lisa Staude | F. Bethke | Jörg Windsheimer | Michael Kirsch | R. Daniels | Klaus-Peter Gottwald | W. Elias | O. Hoffmann | Christopher Pilz | B. Wagner | K. Karageorgiou | A. Kodounis | A. Papadimitriou | N. Vlaikidis | Evaggelos Koutlas | P. Papathanassopoulos | M. Rottoli | C. Florio | L. Grimaldi | E. Millefiorini | T. Koudriavtseva | F. Perla | Sandra Quinones Aguilar | L. L. Lopez | Rocio Marquez Estudillo | M. C. Wittebol | J. C. Baart | A. V. van Golde | P. Pop | M. Bos (Geldrop) | Angelique Schyns-Soeterboek | A. van Diepen | G. Verheul | M. Bos (Helmond) | R. Witjes | L. Sinnige | E. Sanders | R. van Dijl | J. Henselmans | A. Edland | W. Telstad | Tone Hognestad | C. Lund | H. Hovdal | K. Kamaljit | J. Schepel | R. Hogenesch | S. Schüler | Francis Odeh | Olav Korsgaard | Teis Barclay Ingvaldsen | Diana Soares (SCO) | J. Rente | J. M. Guerra | António Leitão | Pinto Marques | M. Baptista | D. Čopíková-Cudráková | Ľ. Procházková | D. Ruiz | Carmen Calles Hernández | M. Solá | Roberto Moro | J. Vidal | Ana Belén Caminero Rodríguez | G. M. Ozaeta | Jordi Batlle Nadal | Amaya Alvarez de Arcaya Esquide | Javier Olascoaga Urtaza | L. R. Torrentà | Martin Wilson | I. Redmond | Tilo Wolf | M. Osei-Bonsu | M. Belhag | Abdullah Shehu | M. Färkkilä | S. Chapuis | M. Barnett | Raymond Lo | E. V. van Munster | K. Buchner

[1]  S. Richman,et al.  Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies , 2017, The Lancet Neurology.

[2]  Pierre Grammond,et al.  Defining secondary progressive multiple sclerosis. , 2016, Brain : a journal of neurology.

[3]  Pierre Grammond,et al.  Defining reliable disability outcomes in multiple sclerosis. , 2015, Brain : a journal of neurology.

[4]  F. Jacques.  Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[5]  F. Lublin,et al.  Natalizumab reduces relapse clinical severity and improves relapse recovery in MS. , 2014, Multiple sclerosis and related disorders.

[6]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[7]  L. Kappos,et al.  Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  Meena Subramanyam,et al.  Risk of natalizumab-associated progressive multifocal leukoencephalopathy. , 2012, The New England journal of medicine.

[9]  L. Kappos,et al.  Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS , 2012, Journal of Neurology.

[10]  Yinshan Zhao,et al.  Natural history of secondary-progressive multiple sclerosis , 2008, Multiple sclerosis.

[11]  O. Pearson,et al.  Contribution of relapses to disability in multiple sclerosis , 2008, Journal of neurology.

[12]  Ludwig Kappos,et al.  A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.

[13]  R. Rudick,et al.  Natalizumab: α4-integrin antagonist selective adhesion molecule inhibitors for MS , 2004 .

[14]  F. Lublin,et al.  Effect of relapses on development of residual deficit in multiple sclerosis , 2003, Neurology.

[15]  C Confavreux,et al.  Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.